Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

2007/01/24 by Wen Xue, Lars Zender, Cornelius Miething +6 · 12 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Research and Treatments #Cancer-related Molecular Pathways #Telomeres, Telomerase, and Senescence

paper · doi:10.1038/nature05529

crossref issued 2007/01/24 · crossref published 2007/01/24 · crossref published-online 2007/01/24 · openalex publication_date 2007/01/24 · crossref created 2007/01/25 · crossref published-print 2007/02/08 · crossref deposited 2023/05/18 · openalex created_date 2025/10/10 · crossref indexed 2026/08/04 · openalex updated_date 2026/08/04

Cited by

• Restoration of p53 function leads to tumour regression in vivo
• Awakening guardian angels: drugging the p53 pathway
• p53 Inhibits Angiogenesis by Inducing the Production of Arresten
• p53 Isoforms: An Intracellular Microprocessor?
• Targeting mutant p53 for efficient cancer therapy
• YPEL3, a p53-Regulated Gene that Induces Cellular Senescence
• A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma
• Global Reorganization of the Nuclear Landscape in Senescent Cells
• BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance
• The Hallmarks of Aging
• The Longevity-Associated Variant of BPIFB4 Reduces Senescence in Glioma Cells and in Patients’ Lymphocytes Favoring Chemotherapy Efficacy
• Experimental cancer treatment [wikipedia]